epcoritamab
abbvie,genmab
['lymphoma', 'epcoritamab', '$abbv', 'abbvie']
#abbvie announces late-breaking results from phase 2 trial of investigational #epcoritamab (#duobodycd3xcd20) in patients with #relapsed #refractory #largebcelllymphoma (#lbcl) at the #eha22 $abbv 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.